Corundum Trust Company’s Johnson & Johnson JNJ Stock Holding History

Corundum Trust Company’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-90	Closed	-$16.7K	–	87
2025 Q3	$16.7K	Buy	+90	New	+$15.4K	0.04%	110
2023 Q3	$609K	Sell	3,911 -324	-8%	-$53.5K	1.82%	14
2023 Q2	$701K	Buy	+4,235	New	+$684K	1.92%	14

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Corundum Trust Company's JNJ Position: Q4 2025 in Review

Corundum Trust Company sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 90 shares — an estimated $16.7K sold.

Corundum Trust Company first reported a position in JNJ in Q2 2023 and held it in 3 quarters. The position peaked at $701K in Q2 2023. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

Corundum Trust Company reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
Corundum Trust Company sold 90 Johnson & Johnson shares in Q4 2025, an estimated $16.7K.
Corundum Trust Company first reported a position in Johnson & Johnson in Q2 2023 and held it in 3 quarters.
Corundum Trust Company's Johnson & Johnson position peaked at $701K in Q2 2023.
4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Corundum Trust Company's 13F filing for Q4 2025, filed 20 Jan 2026.